Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2435643
Max Phase: Preclinical
Molecular Formula: C36H55BrN2O
Molecular Weight: 531.85
Molecule Type: Small molecule
Associated Items:
ID: ALA2435643
Max Phase: Preclinical
Molecular Formula: C36H55BrN2O
Molecular Weight: 531.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCn1c(-c2cc[n+](CCCCCCCCCCC)cc2)cc(=O)c2ccccc21.[Br-]
Standard InChI: InChI=1S/C36H55N2O.BrH/c1-3-5-7-9-11-13-15-17-21-27-37-29-25-32(26-30-37)35-31-36(39)33-23-19-20-24-34(33)38(35)28-22-18-16-14-12-10-8-6-4-2;/h19-20,23-26,29-31H,3-18,21-22,27-28H2,1-2H3;1H/q+1;/p-1
Standard InChI Key: VSSQXQMNJJBTSD-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 531.85 | Molecular Weight (Monoisotopic): 531.4309 | AlogP: 10.02 | #Rotatable Bonds: 21 |
Polar Surface Area: 25.88 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 1.93 | CX LogP: 6.79 | CX LogD: 6.79 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.10 | Np Likeness Score: -0.23 |
1. Kahriman N, Yaylı B, Aktaş A, Iskefiyeli Z, Beriş FŞ, Yaylı N.. (2013) Synthesis, antibacterial and antioxidant activities of new 1-alkyl-4-(1-alkyl-4-oxo-1,4-dihydroquinolin-2-yl)pyridinium bromides., 69 [PMID:24077525] [10.1016/j.ejmech.2013.08.050] |
Source(1):